SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Organogenesis ORG
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
1223 7 0 ORG
Emcee:  Rick Strange Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
323 Barbara, The FDA will not...will not...approve Apligraf in November, or any at Rick Strange-11/15/1997
322 Barbara, If Canadian sales are on target, then this target must be close to zeT. Mann-11/14/1997
321 According to a forum on AOL, FDA approval is expected mid-Nov; i.e that is abouBarbara C. Singer-11/14/1997
320 << Maybe the short sellers should try to get hold of a copy of tFred McCutcheon-11/3/1997
319 To all: Is Novartis moving closer to a takeover of ORG? Contrary to short selAndy Jones-10/31/1997
318 Paul, A very high stature medical journal, but keep in mind that it was my aMarshall Teitelbaum-10/20/1997
317 Of interest -- This being published in the Lancet is highly significant. The LaPaul Shield-10/20/1997
316 >To all: FYI... search.washingtonpost.com IceIceberg-10/20/1997
315 > you lose credibility when you post your "predictions" about ORG Iceberg-10/17/1997
314 Ice, I'll tell you what is wrong with the picture. You seem to wish to porPaul Shield-10/17/1997
313 Andy, Sorry! Actually NEOP is an interesting company. Good luck, RickRick Strange-10/17/1997
312 Actually Rick: My question was regarding a Panel meeting that NEOP might be goiandy harrison-10/17/1997
311 Marshall, One more thing regarding this post. There may be some people who are Paul Shield-10/16/1997
310 Marshall, It's a pleasure to read your posts -- thoughtful and informative.Paul Shield-10/16/1997
309 Bruce, To say there are questions with regards to the trails. "However, IPaul Shield-10/16/1997
308 Rick, I can add a little info. Hope it helps. I probably won't be posting Paul Shield-10/16/1997
307 Andy, I'm only talking about the General Plastic Surgery Devises Panel meetRick Strange-10/16/1997
306 Rick: Are all Panel meeting cancelled for the NOV-DEC time period or just the oandy harrison-10/16/1997
305 I have confirmed with the General Plastic Surgery Devises Panel of the FDA thatRick Strange-10/16/1997
304 Marshall, From a medical standpoint, is grafting onto a severe burn site differRick Strange-10/16/1997
303 JS, The problem is that any time you buy a company because of the potential vaMarshall Teitelbaum-10/15/1997
302 Dear Marshall: As you probably know it is not an end all with no panel scheduleJane Shea-10/15/1997
301 Rick, I didn't get to read the study in any detail, but your point is a goMarshall Teitelbaum-10/15/1997
300 Bruce, All that I'm saying about the burn study is that to enhance autograRick Strange-10/15/1997
299 Steve, I'm currently shorting this company at 30, and yes I'm pretty fBruce Long-10/15/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News